Source: prnewswire.com

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Lisa Deschamps

CEO Approval Rating

90/100

AviadoBio is an England-based gene therapy company that develops and commercializes transformative medicines for neurodegenerative disorders.

AviadoBio received $50M in Corporate Round Funding